glp 1 receptor antagonist GIPR antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys Dual GIP/GLP-1 receptor agonists: New

GLP-1 medications are called GLP-1 receptor agonists or glucagon-like peptide-1 receptor agonists

With prolonged agonist treatment, relative preservation of surface GLP-1Rs was detected with exendin-phe1 (Fig

PubMed: (peer-reviewed) Lee S, et al

Unique MOAs & Combinations To achieve these unique outcomes, manufacturers are investigating novel mechanisms of action (MOAs) to target weight loss via multiple metabolic pathways

Combining real-world datasets in diverse populations is essential to achieve broader applicability

The STAT3 pathway, when improperly regulated, amplifies inflammatory cascade reactions by upregulating key genes responsible for Th17 cell differentiation, a primary driver of tissue damage in inflammatory bowel disease